Send this to a friend

Biostage's first human throat implant successful, autopsy shows

Biostage, a Holliston-based biotech specializing in regenerative medicine to treat diseases of the throat, announced on Tuesday its first esophageal implant resulted in a regenerated esophageal tube. 
The patient, a 75-year-old man, died Monday due to a stroke, but the company’s implant was proven to be effective, the company said in a conference call.
The man’s stroke was unrelated to the implan ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media